Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions (original) (raw)
Table 2.
Microbial metabolites: their synthesis, mechanisms of action, and effects on health and disease
(Co-) Metabolites | Microbial phyla/species | Molecular targets | Effects on health & disease |
---|---|---|---|
Butyrate Synthesized predominantly via butyryl-CoA:acetate CoA transferase pathway [37] | Bacteriodes Ruminococcaceae Lachnospiraceae | Energy source for colonocytesInhibits HDAC [43, 53, 54, 102]Activates GPR41 and GPR43 [38, 39]Activates GPR109A [40]Suppresses nuclear NF-kB activation [40, 46, 47]Modulates PPAR-γ [59, 102] | Increased intestinal barrier function [52, 59]Anti-inflammatory [44, 46, 62, 103]Anti-lipogenic [41]Improves insulin sensitivity [41, 102, 103]Increases energy expenditure [41, 102]Anti-cancer [51, 61] |
Propionate Synthesized predominantly via succinate pathway [36] | Propionibacterium Bacteroides Negativicutes, Selenomonas ruminantium, Roseburia inulinivorans Escherichia coli | Activates GPR41 [89] and GPR43 [38, 39]Upregulates GLP-1, PYY, leptin [34]Increases oxidative stress, alters phospholipid composition, induces inflammation in the brain [179] | Anti-inflammatory [56]Anti-cancerAnti-lipogenic [41]Improves insulin sensitivity [41]Increases energy expenditure [41]Increases satiety [104]Associated with autistic spectrum disorder [179] |
Acetate Synthesized directly from acetyl-CoA or from CO2 via the Wood-Ljungdahl pathway [34] | Most anaerobic gut bacteria studied produce acetate | Energy substrateActivates GPR43 [57, 58] and GPR41 [38, 39]Activates AMPK pathway [34] | Anti-inflammatory [57, 58]Anti-lipogenic [41]Improves insulin sensitivity [41]Increases energy expenditure [41]Reduces glycemia in diabetic rodent models [34]Protects against asthma [90] |
TMA Cleavage from choline via CutC & CutD [108] and from _L_-carnitine via YeaW & YeaX or CntA & CntB [111] | Desulfovibrio Proteus mirabilis Ruminococcus Akkermansia muciniphilia | TAAR5 [118]Potentially others | Excessive levels lead to fish malodor syndrome |
TMAO Oxidized from TMA by FMO3 in liver [120] | Osmolyte [116]Mechanisms remains unknown | Accelerates atherosclerosis [15, 112, 115]Contributes to kidney dysfunction and chronic kidney disease [116] | |
Indole Synthesized from tryptophan via tryptophanase | Lactobacillus Bifidobacterium longum Bacteroides fragilis, Parabacteroides distasonis Clostridium bartlettii E. hallii | Activates AhR [125]Modulates GLP-1 secretion [131] | Maintains host-microbe homeostasis at mucosal surface [125–127]Signals with intestinal L cells to influence host metabolism [131] |
Indole sulfate Hepatic sulfonation from indole | CytotoxicProduces free radicals [142]Stimulates endothelial release of microparticles [140]Enhances monocyte adhesion to vascular endothelium [141] | Induces renal and vascular dysfunction [139–141]Associated with chronic kidney disease [138]Associated with cardiovascular disease [141] | |
Indole-3-aldehyde Synthesized from tryptophan via unidentified enzymes | Lactobacillus | Activates AhR resulting in IL-22 production [125] | Maintains host-microbe homeostasis at mucosal surface [125] |
IPA Synthesized from tryptophan | Clostridium sporogenes | Activates PXR [132]Scavenges hydroxyl radicals [134]Reduces DNA damage and lipid peroxidation in neurons [135]Inhibits beta-amyloid fibril formation [134] | Maintains intestinal barrier function and mucosal homeostasis [132]Anti-oxidant [134, 135, 137]Protects against ischemia-induced neuronal damage [134]Potential therapy for Alzheimer’s disease [134] |
PCS Hepatic sulfination of p-cresol, which is synthesized from tyrosine by hydroxyphenylacete decarboxylase [144] | Clostridium difficile | Damages cell membranes [154]Induces apoptosis [155]Activates NADPH oxidase [156]Activates JNK and p38-MAPK [157]Activates Rho-K [158]Activate EGF receptor [159] | Accumulates in and predicts chronic kidney disease [146–149] |
EPS Hepatic sulfination of 4-ethylphenol, potentially from paracoumaric acid via decarboxylase and vinyl phenol reductase or from genistein | Produced by unknown commensal bacteria | No specific molecular targets identified but assumed to be similar to para-cresol sulfate | Associated with autistic spectrum disorder [28]Potential uremic toxin [153] |
HYA Derived from linoleic acid via linoleate isomerase activity [169] | Lactobacillus plantarum | Activates GPR40 [176]Activates Nrf2 [175] | Maintains intestinal barrier [176]Anti-inflammatory [175] |
CLA CLnA Derived from linoleic acid via linoleate isomerase activity [169] | Lachnospiraceae Lactobacillus Bifidobacteria Faecalibacterium prausnitzii Propionibacterium | Modulates PPARγ [171]Activates PPARα [172]Inhibits cyclooxygenase and lipoxygenase [173, 174]Modulates cytokine production and T-cell responses [180] | Reduces adiposity [170]Improves insulin sensitivity [170]Anti-cancer [170]Reduces atherosclerosis [170]Anti-inflammatory [170] |